Key Developments For USANA Health Sciences Inc
USANA Health Sciences Inc (USNA.O) (Nasdaq)
USANA Health Sciences, Inc. Launches Vitamin D Supplement
USANA Health Sciences, Inc. announced that it has launched its seasonal Vitamin D supplement. The supplement will be available every year from November to March, the months when many people do not get enough vitamin D.
USANA Health Sciences, Inc. Supported Clinical Study Demonstrates Improved Bone Health in Girls
USANA Health Sciences, Inc. announced that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA`s Active Calcium Chewable supplement improves bone health in young girls. The double-blind, placebo-controlled study involved 20 pairs of identical twin girls, ages 9-12 years old, who were randomly assigned to receive USANA`s Active Calcium Chewable or a matching placebo. The results of the study found that after six months of supplementation, Active Calcium Chewable improved measures of bone mineral content, bone mineral density, and bone strength in these girls.
USANA Health Sciences, Inc. Raises FY 2009 Guidance
USANA Health Sciences, Inc. raised fiscal 2009 guidance and expects consolidated net sales to be between $431 million and $434 million earnings per share (EPS) to be between $2.07 and $2.10. According to Reuters Estimates, analysts are expecting the Company to report EPS of $2.07 for fiscal 2009. The Company cited that another solid quarter as the primary reason for the positive guidance.
USANA Health Sciences, Inc. Launches Probiotic Plus
USANA Health Sciences, Inc. announced that it has launched Probiotic Plus, a new probiotic food supplement.
USANA Health Sciences, Inc. Announces Supported Clinical Study Results
USANA Health Sciences, Inc. announced results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD). The recently completed study confirms that lifestyle change can significantly improve outcomes in subjects with metabolic syndrome. Metabolic syndrome is a pre-diabetic state that involves multiple symptoms including central obesity, insulin resistance, elevated blood lipids, elevated blood glucose, and high blood pressure. The 12-week-long study was conducted with 60 people diagnosed with metabolic syndrome. Subjects followed an Internet-based lifestyle modification program that included the Company's nutritional supplements, moderate exercise and a low-glycemic diet including USANA's nutritional shakes and bars. Over the 12-week program, subjects in the study lost an average of 12 pounds and experienced significant improvements in measures of glycemic control, cardiovascular risk factors, inflammation and antioxidant status. Importantly, by the end of the trial, one-third of the subjects no longer met the criteria for metabolic syndrome.
